Mesoblast Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MESO | SLDB | LCTX | RXRX | VCEL | BCDA | |
|---|---|---|---|---|---|---|
| Market cap | 1.85B | 719.48M | 241.30M | 2.15B | 2.08B | 15.44M |
| P/E (TTM) | — | — | — | — | 88.3 | — |
| Forward P/E | 31.4 | -3.9 | -6.9 | -4.4 | 48.0 | -1.8 |
| Price/book | 3.3 | 1.9 | 4.0 | 2.3 | 5.6 | 5.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −19.79% | +7.70% | −46.93% | −31.92% | +17.26% | −34.19% |
| Today | −0.14% | −2.33% | −4.01% | −8.03% | +1.30% | −1.92% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All MESO news ›Buy, hold, sell: Mesoblast, Transurban, NextDC shares
The market has started the new week in the green. S&P/ASX 200 Index (ASX: XJO) shares are up 0.4% to 8,749.7 points on Monday. Among the 11 market sectors, information technology is in the lead today, up 2.3%. The consumer staples sector…
Which ASX Penny Stocks Are Worth Watching in October 2026, Including Mesoblast (ASX:MSB)?
What Is Weighing on Worley (ASX:WOR) Despite a Fatter Backlog? Why Is Arena REIT (ASX:ARF) Rallying on the Edge Sale? How Are Bond Yields Weighing on Atlas Arteria (ASX:ALX)? How Would an Austal USA Sale Reshape Austal (ASX:ASB)? Mesoblast…
What Are Brokers Saying About Mesoblast (ASX:MSB), Dicker Data (ASX:DDR) and ASX Limited (ASX:ASX)?
Are Copper-Zinc Prices Opening a Door for Anax (ASX:ANX)? Why Did TPG Telecom (ASX:TPG) Slide on SpaceX Spectrum News? How Does IperionX (ASX:IPX) Plan a US Titanium Listing Shift? What Lifted Sandfire (ASX:SFR) as Copper Miners Rallied?…
Will Mesoblast's Back Pain Trial Define Its Year (ASX:MSB)?
3 Australian Growth Stocks With Impressive Revenue Growth 4DMedical (ASX:4DX) Hits a Key Technical Roadblock 3 Australian Dividend Stocks To Watch for High Yields Mesoblast's late-stage, randomised controlled trial is testing…
Why Are Mesoblast (ASX:MSB) Shares Slipping Despite FDA Approval?
Can Vanguard's VAP (ASX:VAP) extend its property rally? Will Vanguard's VGS (ASX:VGS) gain from a softer Aussie dollar? Which way next for Betashares ATEC (ASX:ATEC) after tech lagged? Why Is Westpac (ASX:WBC) Lifting Saver Rates Alongside…
Has Mesoblast (ASX:MSB) Cleared a Key FDA Manufacturing Hurdle for Ryoncil?
The company said the FDA approved the use of a T-cell Proliferation Inhibition BioAssay, known as TIBA, for release and stability monitoring of all new commercial lots of Ryoncil. The product is a mesenchymal stromal cell therapy made from…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
kalkinemedia.com5
-
fool.com.au1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.